Synthetic Biologics, Inc News Headlines

SYN 
$2.36
*  
0.09
3.67%
Get SYN Alerts
*Delayed - data as of Mar. 3, 2015 10:55 ET  -  Find a broker to begin trading SYN now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    SYN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Synthetic Biologics: A Speculative Small Cap Packed With Power
2/10/2015 9:19:00 AM - Seeking Alpha


Teva Pharmaceutical Industries: Is It Time To Buy Or Sell?
1/1/2015 3:27:00 AM - Seeking Alpha


Synthetic Biologics Commences Phase Ib Study on SYN-004 - Analyst Blog
12/31/2014 2:40:00 PM - Investopedia


ARIA Widens Sales Turf, NRX Skips A Beat, NDRM Triples On Parkinson''s Study
12/30/2014 11:22:00 PM - RTT News


ARIA Widens Sales Turf, NRX Skips A Beat, NRDM Triples On Parkinson's Study
12/30/2014 11:12:00 PM - RTT News


Synthetic Biologics Unveils Top-Line Safety Data on SYN-004 - Analyst Blog
12/29/2014 5:40:00 AM - Investopedia


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Digesting The GMO Food Controversy And What It Means For Your Investment Portfolio
7/10/2014 11:33:00 AM - Seeking Alpha


Why I'm Short Synthetic Biologics After Phase II Relapsing-Remitting MS Data
5/19/2014 5:53:00 PM - Seeking Alpha


AmpliPhi Biosciences: A Speculative Play In Biopharmaceuticals Too Compelling To Ignore
4/11/2014 9:49:00 AM - Seeking Alpha


Are Tapeworms The Conceptual Key To The Next Multiple Sclerosis Blockbuster?
4/10/2014 11:06:00 AM - Seeking Alpha


OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha


Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk
3/11/2014 8:30:00 AM - Seeking Alpha


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Synthetic Biologics: Randal Kirk And A Robust Pipeline For 2014
12/23/2013 2:38:00 AM - Seeking Alpha


Synthetic Biologics' Sniper Approach To Infectious Diseases
5/29/2013 4:24:00 AM - Seeking Alpha


Genetically Modified Food Investing
4/30/2013 4:09:00 AM - Seeking Alpha


Reason To Track Astex And Adeona
1/30/2012 1:42:00 PM - Seeking Alpha


Analysis Of Noteworthy Institutional 5% Ownership Filings For Wednesday And Thursday
1/26/2012 6:29:00 PM - Seeking Alpha


3 Undervalued Biotechs With Buyout Potential
8/3/2011 8:02:00 AM - Seeking Alpha


Adeona Pharmaceuticals Looks Stronger After Positive Findings
6/5/2011 6:48:00 AM - Seeking Alpha


Aedonas Meets Primary Outcome of Clinical Study and More
4/15/2011 3:36:00 PM - Seeking Alpha


Biotech Catalysts for Q2 2011
4/7/2011 9:00:00 AM - Seeking Alpha


Adeona Pharmaceuticals Addresses the Needs of Large Pharma
12/12/2010 9:01:00 AM - Seeking Alpha


Cramer's Lightning Round - Oracle's Gift of Profitability (10/20/10)
10/21/2010 6:52:00 AM - Seeking Alpha